ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
Dow Jones
44.296,51
0,97%
Euro vs US Dollar
1,04753
0,55%
Bitcoin
98.132,01
0,09%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Enzo Biochem Inc (ENZ)

  7. Enzo Biochem Inc (ENZ) News

ENZ

Enzo Biochem (ENZ)

Enzo Biochem Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ENZ
DatumZeitQuelleÜberschriftSymbolFirma
30/10/202400h59GlobeNewswire Inc.Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendNYSE:ENZEnzo Biochem Inc
29/10/202422h04Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
24/09/202423h19Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
14/08/202422h15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
02/08/202422h15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
25/07/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
25/07/202423h22Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
25/07/202401h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
13/06/202422h20GlobeNewswire Inc.Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
13/06/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
24/05/202422h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
24/05/202422h44Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
13/03/202421h26GlobeNewswire Inc.Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNYSE:ENZEnzo Biochem Inc
28/02/202401h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
27/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
27/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
14/02/202416h23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
13/02/202415h35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ENZEnzo Biochem Inc
03/02/202403h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
03/02/202403h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
03/02/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
01/02/202414h33Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
21/12/202322h48Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNYSE:ENZEnzo Biochem Inc
21/12/202322h15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:ENZEnzo Biochem Inc
15/12/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ENZEnzo Biochem Inc
15/12/202322h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
28/11/202323h16Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NYSE:ENZEnzo Biochem Inc
03/11/202322h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ENZEnzo Biochem Inc
30/10/202322h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:ENZEnzo Biochem Inc
30/10/202321h50Edgar (US Regulatory)Form 8-K - Current reportNYSE:ENZEnzo Biochem Inc
 Showing the most relevant articles for your search:NYSE:ENZ

Kürzlich von Ihnen besucht

CCOM
US30
US 30
NYSE
NKE
Nike
FX
EURGBP
Euro vs Sterling
FX
EURJPY
Euro vs Yen
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
AMEX
XLF
Financial Select Sector
COIN
DOGEUSD
Dogecoin
COIN
XRPUSD
Ripple
DBI
DAX
DAX
NYSE
JPM
JP Morgan Chase
NASDAQ
NVDA
NVIDIA
TG
NOV
Novo Nordisk
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten